The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices

References

• Castelli MS, McGonigle P, Hornby PJ. The pharmacology and therapeutic applications of monoclonal antibodies. Pharmacol Res Perspect. 2019 Dec;7(6):e00535.
   PubMed Web of Science ®Google Scholar
• Eton D, DR Egginton, JS Ridgeway, et al. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. PROM. 2012 Aug 39. DOI:https://doi.org/10.2147/PROM.S34681
   Google Scholar
• Dobler CC, Harb N, Maguire CA, et al. Treatment burden should be included in clinical practice guidelines. BMJ. 2018 Oct; p. k4065. DOI:https://doi.org/10.1136/bmj.k4065
   Google Scholar
• Schwartzman S, Morgan GJ. Does route of administration affect the outcome of TNF antagonist therapy? Arthritis Res Ther. 2004 Jun;6(S2). DOI:https://doi.org/10.1186/ar996
   Google Scholar
• Navarro-Millán I, Herrinton LJ, Chen L, et al. Comparative effectiveness of etanercept and adalimumab in patient reported outcomes and injection-related tolerability. PLOS ONE. 2016 Mar;11(3):e0149781.
   PubMed Web of Science ®Google Scholar
• Tran V-T, Montori VM, Ravaud P. Is My Patient Overwhelmed? Mayo Clin Proc. 2020 Mar;95(3):504–512.
   PubMedGoogle Scholar
• Weinhold T, Del Zotto M, Rochat J, et al. Improving the safety of disposable auto-injection devices: a systematic review of use errors. AAPS Open. Dec 2018;4(1).doi:https://doi.org/10.1186/s41120-018-0027-z
   Google Scholar
• “CIMZIA (certolizumab pegol) [package insert]. Smyrna GA: UCB, Inc.; 2019. Cited 2021 Feb 03: https://www.cimzia.com/themes/custom/cimzia/docs/CIMZIA_full_prescribing_information.pdf.
   Google Scholar
• “FASENRA (benralizumab) [package insert]. Wilmington DE: AstraZeneca Pharmaceuticals; 2019.
   Google Scholar
• Lang VA, Nalan D. Combination product patient training: how are patients trained and who conducts the training?, presented at the 2018 Design of Medical Devices Conference, Minneapolis, Minnesota, USA, Apr. 2018. doi: https://doi.org/10.1115/DMD2018-6956.
   Google Scholar
• Schiff M, Saunderson S, Mountian I, et al. Chronic disease and self-injection: ethnographic investigations into the patient experience during treatment. Rheumatol Ther. 2017 Dec;4(2):445–463.
   PubMed Web of Science ®Google Scholar
• Rinaldi A, Katsaros D, Hawthorne J, et al. The current paradigm for biologic initiation: a mixed-methods exploration of practices, unmet needs, and innovation opportunities in self-injection training. Expert Opin Drug Deliv. 2021 Aug;18(8):1151–1168.
   PubMed Web of Science ®Google Scholar
• Oleen-Burkey M, Pardo G. Examining the influence of behavioral factors on compliance and persistence with glatiramer acetate injection for relapsing-remitting multiple sclerosis. J Neurol Neurophysiol. 2014;05(3). DOI:https://doi.org/10.4172/2155-9562.1000205
   Google Scholar
• Mann DM, Chen J, Chunara R, et al. COVID-19 transforms health care through telemedicine: evidence from the field. J Am Med Inform Assoc. 2020 May;27(7):1132–1135.
   PubMed Web of Science ®Google Scholar
• Rittberg R, Dissanayake T, Katz SJ. A qualitative analysis of methotrexate self-injection education videos on YouTube. Clin Rheumatol. 2016 May;35(5):1329–1333.
   PubMed Web of Science ®Google Scholar
• Tallman K. Communication practices of physicians with high patient-satisfaction ratings. Perm J. 2007 Dec;11(1). DOI:https://doi.org/10.7812/TPP/06-106
   Google Scholar
• Cox D, Stone J. Managing self-injection difficulties e page in patients with relapsing-remitting ce multiple sclerosis. J Neurosci Nurs. 2006;38(3):5.
   PubMedGoogle Scholar
• Mohr DC, Cox D, Epstein L, et al. Teaching patients to self-inject: pilot study of a treatment for injection anxiety and phobia in multiple sclerosis patients prescribed injectable medications. J Behav Ther Exp Psychiatry. 2002 Mar;33(1):39–47.
   PubMed Web of Science ®Google Scholar
• Zimmer PA, Braun LT, Fraser R, et al. Promoting Success in Self-Injection: listening to Patients. Medsurg Nurs. 2015 Aug;24(4):279–282.
   PubMedGoogle Scholar
• van den Bemt BJF, Gettings L, Domańska B, et al. A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience. Drug Deliv. 2019 Mar;26(1):384–392.
   PubMed Web of Science ®Google Scholar
• Tran V-T, Harrington M, Montori VM, et al. Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform. BMC Med. 2014 Dec;12(1):109.
   PubMedGoogle Scholar
• Tran G, Dube B, Kingsbury SR, et al. Investigating the patient acceptable symptom state cut-offs: longitudinal data from a community cohort using the shoulder pain and disability index. Rheumatol Int. 2020 Apr;40(4):599–605.
   PubMed Web of Science ®Google Scholar
• Rogers E, Yost K, Rosedahl J, et al. Validating the Patient Experience with Treatment and Self-Management (PETS), a patient-reported measure of treatment burden, in people with diabetes. PROM. 2017Nov;8:143–156.
   Google Scholar
• Keininger D, Coteur G. Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ). Health Qual Life Outcomes. 2011;9(1):2.
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertension. 2008 May;10(5):348–354.
   PubMed Web of Science ®Google Scholar
• Hojat M, Mangione S, Nasca TJ, et al. The Jefferson Scale of Physician Empathy: development and preliminary psychometric data. Educ Psychol Meas. 2001 Apr;61(2):349–365.
   Web of Science ®Google Scholar
• Kottak N, Tesser J, Leibowitz E, et al. Ethnographic observational study of the biologic initiation conversation between rheumatologists and biologic-naive rheumatoid arthritis patients. Arthritis Care Res. 2018 Jul;70(7):997–1004.
   Web of Science ®Google Scholar
• Arthur W Jr., Bennett W Jr., Stanush PL, et al. Factors that influence skill decay and retention: a quantitative review and analysis. Human Performance. 1998 Mar;11(1):57–101
   Web of Science ®Google Scholar
• Clark SE. Training decay selection for usability validation. Proc Int Symp Hum Factors. 2016 Jun;5(1):76–83.
   Google Scholar
• Nakatani Y, Matsumura M, Monden T, et al. Improvement of glycemic control by re-education in insulin injection technique in patients with diabetes mellitus. Adv Ther. 2013 Oct;30(10):897–906.
   PubMed Web of Science ®Google Scholar
• Singh AG, Singh S, Singh PP. YouTube for information on rheumatoid arthritis — a wakeup call? J Rheumatol. 2012 May;39(5):899–903.
   PubMed Web of Science ®Google Scholar
• Tolu S, Yurdakul OV, Basaran B, et al. English-language videos on YouTube as a source of information on self-administer subcutaneous anti-tumour necrosis factor agent injections. Rheumatol Int. 2018 Jul;38(7):1285–1292.
   PubMed Web of Science ®Google Scholar
• Vermeire S, D’heygere F, Nakad A, et al. Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study. PPA. 2018Jul;12:1193–1202.
   Google Scholar
• Borrás-Blasco J, Gracia-Pérez A, Rosique-Robles JD, et a.l Acceptability of switching Adalimumab from a prefilled syringe to an autoinjection pen. Expert Opin Biol Ther. 2010 Mar;10(3):301–307.
   PubMed Web of Science ®Google Scholar
• Jüngst C, Gräber S, Simons S, et al. Medication adherence among patients with chronic diseases: a survey-based study in pharmacies. QJM. 2019 Jul;112(7):505–512.
   PubMed Web of Science ®Google Scholar
• Heckman BW, Mathew AR, Carpenter MJ. Treatment burden and treatment fatigue as barriers to health. Curr Opin Psychol. 2015Oct;5:31–36.
   PubMed Web of Science ®Google Scholar
• Turner AP, Williams RM, Sloan AP, et al. Injection anxiety remains a long-term barrier to medication adherence in multiple sclerosis. Rehabil Psychol. 2009;54(1):116–121.
   PubMed Web of Science ®Google Scholar